These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 12054164

  • 1. The effects of growth hormone replacement therapy on bone metabolism in adult-onset growth hormone deficiency: a 2-year open randomized controlled multicenter trial.
    Bex M, Abs R, Maiter D, Beckers A, Lamberigts G, Bouillon R.
    J Bone Miner Res; 2002 Jun; 17(6):1081-94. PubMed ID: 12054164
    [Abstract] [Full Text] [Related]

  • 2. [Long-term effects of 7-year growth hormone substitution on bone metabolism, bone density, and bone quality in growth hormone-deficient adults].
    Wilhelm B, Kann PH.
    Med Klin (Munich); 2004 Oct 15; 99(10):569-77. PubMed ID: 15490072
    [Abstract] [Full Text] [Related]

  • 3. The impact of idiopathic childhood-onset growth hormone deficiency (GHD) on bone mass in subjects without adult GHD.
    Lange M, Müller J, Svendsen OL, Kastrup KW, Juul A, Feldt-Rasmussen U.
    Clin Endocrinol (Oxf); 2005 Jan 15; 62(1):18-23. PubMed ID: 15638865
    [Abstract] [Full Text] [Related]

  • 4. Effect of growth hormone replacement on BMD in adult-onset growth hormone deficiency.
    Snyder PJ, Biller BM, Zagar A, Jackson I, Arafah BM, Nippoldt TB, Cook DM, Mooradian AD, Kwan A, Scism-Bacon J, Chipman JJ, Hartman ML.
    J Bone Miner Res; 2007 May 15; 22(5):762-70. PubMed ID: 17280527
    [Abstract] [Full Text] [Related]

  • 5. Comparative results of a 4-year study on cardiovascular parameters, lipid metabolism, body composition and bone mass between untreated and treated adult growth hormone deficient patients.
    Fideleff HL, Boquete HR, Stalldecker G, Giaccio AV, Sobrado PG.
    Growth Horm IGF Res; 2008 Aug 15; 18(4):318-24. PubMed ID: 18289903
    [Abstract] [Full Text] [Related]

  • 6. Long-term effects of growth hormone (GH) on bone mineral status and bone turnover markers in patients with isolated GH deficiency and multiple pituitary hormone deficiency.
    Gonc EN, Kandemir N.
    Clin Endocrinol (Oxf); 2007 May 15; 66(5):672-7. PubMed ID: 17381489
    [Abstract] [Full Text] [Related]

  • 7. Serum levels of insulin-like growth factor binding proteins (IGFBP)-4 and -5 correlate with bone mineral density in growth hormone (GH)-deficient adults and increase with GH replacement therapy.
    Thorén M, Hilding A, Brismar T, Magnusson P, Degerblad M, Larsson L, Sääf M, Baylink DJ, Mohan S.
    J Bone Miner Res; 1998 May 15; 13(5):891-9. PubMed ID: 9610754
    [Abstract] [Full Text] [Related]

  • 8. Bone mineral density in patients with growth hormone deficiency: does a gender difference exist?
    Hitz MF, Jensen JE, Eskildsen PC.
    Clin Endocrinol (Oxf); 2006 Dec 15; 65(6):783-91. PubMed ID: 17121531
    [Abstract] [Full Text] [Related]

  • 9. Effects of growth hormone administration on bone mineral metabolism, PTH sensitivity and PTH secretory rhythm in postmenopausal women with established osteoporosis.
    Joseph F, Ahmad AM, Ul-Haq M, Durham BH, Whittingham P, Fraser WD, Vora JP.
    J Bone Miner Res; 2008 May 15; 23(5):721-9. PubMed ID: 18052753
    [Abstract] [Full Text] [Related]

  • 10. [Growth hormone deficiency, its influence on bone mineral density and risk of osteoporotic fractures].
    Kuzma M, Payer J.
    Cas Lek Cesk; 2010 May 15; 149(5):211-6. PubMed ID: 20629339
    [Abstract] [Full Text] [Related]

  • 11. Effect of growth hormone therapy and puberty on bone and body composition in children with idiopathic short stature and growth hormone deficiency.
    Högler W, Briody J, Moore B, Lu PW, Cowell CT.
    Bone; 2005 Nov 15; 37(5):642-50. PubMed ID: 16139578
    [Abstract] [Full Text] [Related]

  • 12. Long-term skeletal effects of recombinant human growth hormone (rhGH) alone and rhGH combined with alendronate in GH-deficient adults: a seven-year follow-up study.
    Biermasz NR, Hamdy NA, Pereira AM, Romijn JA, Roelfsema F.
    Clin Endocrinol (Oxf); 2004 May 15; 60(5):568-75. PubMed ID: 15104559
    [Abstract] [Full Text] [Related]

  • 13. Low dose recombinant human growth hormone normalizes bone metabolism and cortical bone density and improves trabecular bone density in growth hormone deficient adults without causing adverse effects.
    Amato G, Izzo G, La Montagna G, Bellastella A.
    Clin Endocrinol (Oxf); 1996 Jul 15; 45(1):27-32. PubMed ID: 8796135
    [Abstract] [Full Text] [Related]

  • 14. The effects of gonadectomy on bone size, mass, and volumetric density in growing rats are gender-, site-, and growth hormone-specific.
    Zhang XZ, Kalu DN, Erbas B, Hopper JL, Seeman E.
    J Bone Miner Res; 1999 May 15; 14(5):802-9. PubMed ID: 10320529
    [Abstract] [Full Text] [Related]

  • 15. Effect of long-term growth hormone treatment on bone mass and bone metabolism in growth hormone-deficient men.
    Bravenboer N, Holzmann PJ, ter Maaten JC, Stuurman LM, Roos JC, Lips P.
    J Bone Miner Res; 2005 Oct 15; 20(10):1778-84. PubMed ID: 16160735
    [Abstract] [Full Text] [Related]

  • 16. Growth hormone treatment in adults with adult-onset growth hormone deficiency increases iliac crest trabecular bone turnover: a 1-year, double-blind, randomized, placebo-controlled study.
    Brixen K, Hansen TB, Hauge E, Vahl N, Jørgensen JO, Christiansen JS, Mosekilde L, Hagen C, Melsen F.
    J Bone Miner Res; 2000 Feb 15; 15(2):293-300. PubMed ID: 10703931
    [Abstract] [Full Text] [Related]

  • 17. Two years of growth hormone (GH) treatment increases bone mineral content and density in hypopituitary patients with adult-onset GH deficiency.
    Johannsson G, Rosén T, Bosaeus I, Sjöström L, Bengtsson BA.
    J Clin Endocrinol Metab; 1996 Aug 15; 81(8):2865-73. PubMed ID: 8768843
    [Abstract] [Full Text] [Related]

  • 18. Ten-year GH replacement increases bone mineral density in hypopituitary patients with adult onset GH deficiency.
    Götherström G, Bengtsson BA, Bosaeus I, Johannsson G, Svensson J.
    Eur J Endocrinol; 2007 Jan 15; 156(1):55-64. PubMed ID: 17218726
    [Abstract] [Full Text] [Related]

  • 19. Positive linear growth and bone responses to growth hormone treatment in children with types III and IV osteogenesis imperfecta: high predictive value of the carboxyterminal propeptide of type I procollagen.
    Marini JC, Hopkins E, Glorieux FH, Chrousos GP, Reynolds JC, Gundberg CM, Reing CM.
    J Bone Miner Res; 2003 Feb 15; 18(2):237-43. PubMed ID: 12568401
    [Abstract] [Full Text] [Related]

  • 20. Withdrawal of long-term physiological growth hormone (GH) administration: differential effects on bone density and body composition in men with adult-onset GH deficiency.
    Biller BM, Sesmilo G, Baum HB, Hayden D, Schoenfeld D, Klibanski A.
    J Clin Endocrinol Metab; 2000 Mar 15; 85(3):970-6. PubMed ID: 10720025
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.